VC-backed AGTC debuts IPO
Florida-based biotech company Applied Genetic Technologies Corp. has launched its IPO after pricing its offering of over 4.16 million shares at $12 per share. The stock began trading Thursday on the NASDAQ under the ticker symbol "AGTC." BMO Capital Markets and Wedbush PacGrow Life Sciences are the lead underwriters. Its backers include InterWest Partners, Skyline Ventures, Intersouth Partners, MedImmune Ventures, Osage University Partners, SR One and Alta Partners.
27 March 2014•2 mins read
